Potential central nervous system antitumor agents. Hydantoin derivatives.

@article{Peng1975PotentialCN,
  title={Potential central nervous system antitumor agents. Hydantoin derivatives.},
  author={Geoffrey W. Peng and Victor E. Marquez and John S. Driscoll},
  journal={Journal of medicinal chemistry},
  year={1975},
  volume={18 8},
  pages={846-9}
}
Hydantoin derivatives of varying lipophilic character were prepared as nitrogen mustard carriers for CNS antitumor evaluation. Activity was studied in the murine ependymoblastoma brain tumor system. Multiple cures were observed for three of the four analogs examined. The compounds were also active in the intraperitoneal leukemia L1210 and P388 systems as well as in B16 melanoma and Lewis lung carcinoma.